Jim Cramer’s Take on Healthcare Stocks On CNBC’s “Mad Money Lightning Round,” Jim Cramer shared his insights on various stocks. When asked about ImmunoGen, Inc., he noted that it is now a property of AbbVie and swiftly moved on. Cramer expressed his reluctance to invest …

Read more

U.S. stocks traded mixed toward the end of trading, with changes in the Nasdaq Composite drawing particular attention on Tuesday. The Dow experienced a slight dip of 0.53% to 37,484.13, while the NASDAQ climbed 0.15% to 14,866.50. The S&P 500 also experienced a fall, declining …

Read more

Legacy automakers faced a tumultuous 2023, contending with the challenge of constructing “data centers on wheels” while contending with the relentless competitive onslaught from electric vehicle (EV) pioneer Tesla (NASDAQ: TSLA). Rising EV production costs, surging union wages, and escalating interest rates curtailed demand for …

Read more

A triumphant narrative of resilience and strategic prowess across three divergent industries emerges in the ongoing roller-coaster, where markets teeter on the brink of uncertainty with stocks at 52-week lows. Alibaba’s Fortitude Alibaba’s (NYSE:BABA) ability to consistently generate substantial revenue growth is a fundamental strength …

Read more

ChargePoint (NYSE:CHPT) may have suffered a nearly crippling 78% loss in the past year, but it remains poised for a potential redemption. Specializing in EV charging infrastructure, the company finds itself in an industry with immense relevance. With the gradual proliferation of EVs in the …

Read more

peterschreiber.media As the clock ticks towards 2024, financial powerhouse Raymond James has forecasted a market tango, characterized by a shifting focus on defensive stocks in the first half before giving way to a surge in cyclicals in the latter half of the trading year. Insights …

Read more

The Verbal Skirmish The lead-up to the 2024 presidential race has witnessed an electrifying exchange of words between US President Joe Biden and former President Donald Trump. Biden, in a speech delivered in South Carolina, revived the age-old feud by branding his predecessor a “loser.” …

Read more

I’m delighted to present the first LatAm Tech Weekly of 2024. This week’s edition is unique as it delves into an insightful analysis shedding light on the upcoming trends in the venture capital market. Before we delve into that, let’s take a quick look back …

Read more

Nvidia Corp.’s NVDA has enraptured investors with a strategic trajectory fueled by robust free cash flow (FCF) and an evolving approach to recurring revenue. The company is poised for substantial growth and market revaluation. As of 2023, the stock has outpaced its peers, returning a …

Read more

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500 also rose, gaining 0.55% to 4,722.93. Check This Out: Don’t Miss …

Read more